long acting injectable

At my program, most attendings essentially scoff at starting Abilify Aristada or Maintena for patients with schizophrenia. Not because of the cost, but because they consistently feel that the binding affinity for the partial agonist at dopamine is stronger than other antipsychotics, thus if a...